Key result
Pure TCM is linked to ~66% lower mortality but higher readmissions, with rhythm control improving survival.
Why the study?
Despite its reversibility, the long-term prognosis of tachycardia-induced cardiomyopathy remains poorly defined, particularly compared to other forms of HFrEF.
Does tachycardia-induced cardiomyopathy have different long-term survival and hospitalization outcomes compared to other HFrEF subtypes in patients with acute decompensated HFrEF?
Observational (n=456)
Does tachycardia-induced cardiomyopathy have different long-term survival and hospitalization outcomes compared to other HFrEF subtypes in patients with acute decompensated HFrEF?
Pure tachycardia-induced cardiomyopathy is associated with favorable long-term survival compared to structural HFrEF, but carries a high risk of hospital readmission, highlighting the need for early rhythm control and long-term arrhythmia surveillance.
Answers are grounded in this paper and cite their sources.
Warrants close arrhythmia surveillance in TCM; extends observational data on survival but leaves practice change open.
Background Tachycardia-induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) caused by persistent arrhythmias, primarily atrial fibrillation (AF). Despite its reversibility, the long-term prognosis of TCM remains poorly defined, particularly in comparison to other forms of heart failure with reduced ejection fraction (HFrEF). This study evaluates long-term survival and hospitalization outcomes in patients with pure and impure TCM relative to other HFrEF subtypes. Methods Prospective observational study on patients hospitalized with de novo, acute decompensated HFrEF. Patients were categorized into four groups: pure TCM, impure TCM, idiopathic HF, and structural HF (ischemic and non-ischemic). Follow-up included clinical and echocardiographic assessments, with endpoints of all-cause mortality and unplanned cardiovascular hospitalizations. Results A total of 456 patients (304 males, median age 72.8 years) were enrolled. The median follow-up duration was 3 years (IQR 1.5-5.1 years). AF was the predominant cause of TCM (128 patients, 75.7%). Rhythm control was the preferred strategy in 135 TCM patients (79.9%), with electric cardioversion performed in 60.9%, pharmacological conversion in 8.3%, and primary catheter ablation in 10.7% during the index hospitalization. All four groups demonstrated clinical and laboratory improvements during hospitalization, including a significant reduction in BNP and an improvement in NYHA functional class before discharge. Survival analpysis revealed significant differences in all-cause mortality among the groups, with pure TCM demonstrating the highest survival rates and structural HF the lowest (Figure 1). Compared to structural HF, hazard ratios (HRs) for mortality were significantly lower in pure TCM (HR 0.34; 95% CI 0.21-0.56) and idiopathic HF (HR 0.53; 95% CI 0.32-0.90), while impure TCM showed no significant difference (HR 0.57; 95% CI 0.30-1.07). Within the TCM cohort, an initial rhythm control strategy was associated with superior survival (73% vs. 50%; log-rank p<0.0001). Hospitalization trends differed from mortality outcomes, with both pure and impure TCM groups exhibiting the lowest rates of readmission-free survival (Figure 2). The mean total number of unplanned hospitalizations varied significantly across the four groups (pure TCM: 0.81; 95% CI 0.62-1.00, impure TCM: 0.84; 95% CI 0.51-1.17, idiopathic HF: 0.38; 95% CI 0.20-0.55, structural HF: 0.89; 95% CI 0.68-1.10; p=0.019). Conclusions While pure TCM is associated with favorable long-term survival, it carries a high risk of hospital readmission, underscoring the importance of early rhythm control and long-term arrhythmia surveillance. Structured follow-up strategies may improve outcomes for TCM patients, and further research is warranted to assess the impact of rhythm control on quality of life and hospitalization burden.Overall survival Readmissions
No takes yet. Share an insight, caveat, or question.
Stronati et al. (2025) conducted an observational in Tachycardia-induced cardiomyopathy (TCM) / Heart failure with reduced ejection fraction (HFrEF) (n=456). Pure tachycardia-induced cardiomyopathy (TCM) vs. Structural heart failure was evaluated on All-cause mortality (HR 0.34, 95% CI 0.21-0.56). Pure tachycardia-induced cardiomyopathy was associated with lower all-cause mortality compared to structural heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: